Recruiting Pulmonary Hypertension Studies in Cullman
About Pulmonary Hypertension Clinical Trials in Cullman
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 1 pulmonary hypertension clinical trials recruiting participants in Cullman, AL. These studies are seeking a combined 300 participants. Research is being sponsored by Vertex Pharmaceuticals Incorporated. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Cullman — FAQ
Are there pulmonary hypertension clinical trials in Cullman?
Yes, there are 1 pulmonary hypertension clinical trials currently recruiting in Cullman, AL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Cullman?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cullman research site will contact you about next steps.
Are clinical trials in Cullman free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cullman studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 1 active trials in Cullman are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated October 12, 2026 from ClinicalTrials.gov